{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:21:39Z","timestamp":1780986099404,"version":"3.54.1"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,11,28]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>A middle-aged woman with a history of leiomyosarcoma of the uterus treated with surgery and adjuvant chemotherapy suffered a bulky metastatic recurrence 1\u2009year later. She elected treatment with palliative eribulin, presenting with acute renal failure and electrolyte abnormalities consistent with tumour lysis syndrome on cycle 1\u2009day 8. Despite aggressive supportive care and treatment including intravenous hydration, bicarbonate and rasburicase, she continued to decline, ultimately foregoing haemodialysis in favour of palliative care and passed away in the hospital.<\/jats:p>","DOI":"10.1136\/bcr-2018-224576","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T07:27:18Z","timestamp":1545290838000},"page":"e224576","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma"],"prefix":"10.1136","volume":"11","author":[{"given":"Cindy","family":"Pabon","sequence":"first","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini K","family":"Esnakula","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Daily","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2025082723315716000_11.1.e224576.1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27942"},{"key":"2025082723315716000_11.1.e224576.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70230-3"},{"key":"2025082723315716000_11.1.e224576.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025082723315716000_11.1.e224576.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2011.08.010"},{"key":"2025082723315716000_11.1.e224576.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569"},{"key":"2025082723315716000_11.1.e224576.6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5492\/wjccm.v4.i2.130","article-title":"Tumor lysis syndrome: a clinical review","volume":"4","author":"Mirrakhimov","year":"2015","journal-title":"World J Crit Care Med"},{"key":"2025082723315716000_11.1.e224576.7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90174-N"},{"key":"2025082723315716000_11.1.e224576.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00153-8"},{"key":"2025082723315716000_11.1.e224576.9","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199412000-00010"},{"key":"2025082723315716000_11.1.e224576.10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00280-002-0556-x","article-title":"Acute tumor lysis syndrome in solid tumors--a case report and review of the literature","volume":"51","author":"Baeksgaard","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"2025082723315716000_11.1.e224576.11","doi-asserted-by":"publisher","DOI":"10.1007\/s005200100276"},{"key":"2025082723315716000_11.1.e224576.12","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/82012","article-title":"Tumour lysis syndrome occurring in a patient with metastatic gastrointestinal stromal tumour treated with glivec (Imatinib Mesylate, Gleevec, STI571)","volume":"2007","author":"Pinder","year":"2007","journal-title":"Sarcoma"},{"key":"2025082723315716000_11.1.e224576.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.07.001"},{"key":"2025082723315716000_11.1.e224576.14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2710.2005.00684.x","article-title":"Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature","volume":"30","author":"Chen","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"2025082723315716000_11.1.e224576.15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1447-0756.2010.01454.x","article-title":"A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation","volume":"37","author":"Hiraizumi","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"2025082723315716000_11.1.e224576.16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cnur.2017.01.008","article-title":"Tumor lysis syndrome: a unique solute disturbance","volume":"52","author":"Strauss","year":"2017","journal-title":"Nurs Clin North Am"},{"key":"2025082723315716000_11.1.e224576.17","first-page":"1","article-title":"Spontaneous tumor lysis syndrome due to uterine leiomyosarcoma with lung metastases","volume":"2017","author":"Alaigh","year":"2017","journal-title":"Case Rep Crit Care"},{"key":"2025082723315716000_11.1.e224576.18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14737140.2017.1344098","article-title":"Eribulin in advanced liposarcoma and leiomyosarcoma","volume":"17","author":"Setola","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"2025082723315716000_11.1.e224576.19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jjco\/hyw175","article-title":"Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma","volume":"47","author":"Kawai","year":"2017","journal-title":"Jpn J Clin Oncol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bcr-2018-224576","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-224576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:32:04Z","timestamp":1756362724000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-224576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,19]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/bcr-2018-224576"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-224576","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}